EB-1B Outstanding Researcher Green Card for San Diego Scientists
The EB-1B outstanding researcher category requires a permanent job offer from a U.S. research institution — making it employer-dependent, unlike EB-1A. In San Diego, the dominant EB-1B sponsors are the independent research institutes — Salk, Scripps Research, La Jolla Institute for Immunology, Sanford Burnham Prebys — together with UC San Diego and the larger biotech and genomics R&D departments. The standard is recognition as outstanding in the field: lower than EB-1A's extraordinary ability and accessible to strong early- and mid-career faculty.
San Diego's research core is concentrated on the Torrey Pines mesa and along the La Jolla coastline — a half-mile stretch that holds the Salk Institute, Scripps Research, the La Jolla Institute for Immunology, Sanford Burnham Prebys, and UC San Diego's School of Medicine, all within walking distance of one another. EB-1B in San Diego primarily originates from two routes. First, the independent institutes: when a scientist converts from a postdoctoral fellowship to a permanent faculty or member appointment — Assistant Professor at Salk or Scripps Research, Assistant Member at LJI — the institute can sponsor EB-1B, because the permanent appointment satisfies the job-offer requirement. The institute's own appointment and promotion review constitutes a substantial portion of the EB-1B evidence package.
Second, UC San Diego and industry: a UCSD ladder-rank faculty appointment in the School of Medicine, Jacobs School of Engineering, or Scripps Institution of Oceanography lets the university sponsor EB-1B for outstanding researchers. And San Diego's biotech and genomics employers — Illumina, Dexcom, Neurocrine Biosciences, and the research arms of larger pharma with local campuses — can sponsor EB-1B under the private-employer route, which requires the company to employ at least three full-time researchers and to document its own accomplishments in the field. The researcher's publications, citation record, peer review service, patents, and recognition in the field form the evidence base in every case.
Salk Institute for Biological Studies
Salk sponsors EB-1B for tenure-track faculty (Assistant and Associate Professor) holding permanent appointments; the institute's appointment and promotion review — external letters, faculty committee assessment — serves as institutional documentation of outstanding ability; last-author publications in Cell, Nature, and Science and awards such as Pew Scholar and HHMI Faculty Scholar form the evidence base.
Scripps Research
Scripps Research sponsors EB-1B for faculty in chemistry, immunology, and molecular medicine with permanent appointments; strong records in covalent drug discovery, chemical biology, and structural biology support the original-contributions and scholarly-articles criteria; the Scripps name is recognized by USCIS as a distinguished research institution.
La Jolla Institute for Immunology (LJI)
LJI sponsors EB-1B for Assistant and Associate Members on its tenure-equivalent track; T cell biology, vaccine immunology, and infectious disease researchers qualify through publications in Immunity, Nature Immunology, and Cell, plus NIH study section service and society awards; LJI's NIH-funded independent status supports the institutional-standing argument.
Sanford Burnham Prebys
SBP sponsors EB-1B for permanent faculty in cancer biology, neuroscience, and rare disease research; program leaders and associate professors satisfy the scholarly-articles and original-contributions criteria through high-impact publications and field-recognized discoveries; the institute's NCI-designated cancer center status strengthens the record.
UC San Diego (School of Medicine, Jacobs Engineering, Scripps Oceanography)
UCSD's International Faculty and Scholars Office sponsors EB-1B for ladder-rank faculty; departments in Pharmacology, Neurosciences, Bioengineering, and Scripps Institution of Oceanography routinely support outstanding-researcher petitions; the standardized university process makes UCSD among the most predictable EB-1B sponsors in the metro.
San Diego biotech R&D (Illumina, Dexcom, Neurocrine)
Private employers with substantial research departments can sponsor EB-1B under the three-researcher / documented-accomplishments route; principal and senior scientists at San Diego genomics, diagnostics, and neuroscience companies qualify through commercialized patents, peer-reviewed publications, and recognition in the field — though many industry scientists prefer the employer-independent EB-1A.
Eligibility criteria
EB-1B criteria for San Diego researchers.
EB-1B requires satisfaction of at least two of six criteria, plus a permanent job offer and at least three years of research experience in the field. The six criteria are distinct from — and generally lower-threshold than — the EB-1A criteria. San Diego faculty and members typically satisfy three or four.
CRITERION 01
Prizes or awards for excellence
Pew Scholar in Biomedical Sciences, HHMI Faculty Scholar, Damon Runyon awards, Burroughs Wellcome Career Award, Nomis Distinguished Scientist Award, ACS or AGU society awards — common across Salk, Scripps Research, LJI, and Scripps Oceanography records.
CRITERION 02
Membership in associations requiring outstanding achievement
Elected fellowship in AAAS, the American Academy of Microbiology, or the American Association of Immunologists; editorial board membership at major journals; invitation-only societies that require nomination and peer election, not simply application.
CRITERION 03
Published material about the person
Profiles in The Scientist, STAT News, GenomeWeb, or Cell Press news features; coverage of the researcher's findings in Nature News & Views or institutional press releases picked up by trade media.
CRITERION 04
Judging the work of others
NIH or NSF study section service (ad hoc or standing); grant review for Damon Runyon or Burroughs Wellcome; editorial board service; manuscript peer review for Cell, Nature, Science, Immunity, or JACS. A single well-documented panel satisfies the criterion.
CRITERION 05
Original scientific or scholarly contributions
Discovery of a molecular mechanism with recognized field impact; a synthetic method or assay adopted by other labs documented through citation analysis; a sequencing or diagnostic technology in industry use. Expert declarations describe the contribution's significance.
CRITERION 06
Authorship of scholarly articles
Publications in high-impact journals (Cell, Nature, Science, Immunity, Nature Immunology, JACS, PNAS); citation counts and h-index consistent with outstanding standing in the specific research area.
San Diego EB-1B profiles
What qualifying records look like here.
Representative profiles from San Diego EB-1B petitions. Identifying details have been generalized.
Assistant Professor
Salk Institute — Molecular and Cell Biology Laboratory
Epigenetic regulation of cellular aging and metabolic disease
15 publications (first- or last-author in Cell Metabolism, Nature, Genes & Development)
Pew Scholar in Biomedical Sciences
2 NIH study section ad hoc reviews
Invited speaker at Keystone Symposia and Gordon Research Conferences
Salk sponsored EB-1B through the tenure-track Assistant Professor appointment. The institute's faculty appointment review and external letters anchored the permanent-position requirement; Pew Scholar satisfied prizes; study section service satisfied judging; the publication record satisfied scholarly articles.
NIH R01 (PI) and Damon Runyon-adjacent fellowship history
Editorial board, Journal of Immunology
Invited lecture at the AAI Annual Meeting
LJI sponsored EB-1B; the Associate Member appointment on the institute's tenure-equivalent track served as the permanent job offer. Editorial board membership satisfied judging; the publication and citation record satisfied scholarly articles; original contributions were anchored to mechanistic discoveries cited in field review articles.
Principal Scientist
San Diego genomics company (private-employer EB-1B)
Library preparation chemistry for next-generation sequencing
11 peer-reviewed publications; 9 issued patents
Sequencing chemistry adopted by research labs worldwide
Coverage in GenomeWeb and an industry trade award
Peer reviewer for two genomics methods journals
The employer documented a research department of more than three full-time scientists and a record of patents and products, qualifying it as a private-employer EB-1B sponsor. Original contributions (commercialized chemistry) and scholarly articles were the lead criteria; expert letters explained the field-wide adoption of the platform.
Choosing between pathways
EB-1B vs. EB-1A for San Diego researchers — which path first?
EB-1B and EB-1A are complementary, not competing, green card paths. EB-1B is employer-sponsored — it requires a permanent job offer from a qualifying U.S. research institution. EB-1A is self-petitioned — it requires no employer at all. Both fall in the EB-1 preference category. For San Diego researchers at Salk, Scripps Research, LJI, or UCSD, the most common strategy is to have the institute sponsor EB-1B while the researcher simultaneously self-petitions EB-1A. Two approved I-140s provide maximum flexibility — and because the EB-1A is employer-independent, it follows the scientist to a new institute or into San Diego's biotech sector.
For Indian and Chinese nationals, this parallel strategy is especially important: filing both I-140s as early as the record allows locks in the earliest possible priority date in the EB-1 category, where the backlog — while now present for India and China — remains shorter than EB-2 or EB-3. If EB-1B is denied, EB-1A proceeds independently; if EB-1B is approved first and the priority date is current, I-485 can be filed without waiting. For researchers early enough in their careers that EB-1A is out of reach, EB-1B is the right first step — with EB-1A and NIW as natural follow-ons once the record matures. Consult the Visa Bulletin for current cutoff dates.
FAQ
San Diego EB-1B questions.
Yes, provided the appointment is permanent. EB-1B requires a permanent job offer — for academic research, an offer of permanent employment such as a tenured or tenure-track position or a comparable indefinite research appointment. At Salk, an Assistant Professor on the tenure track satisfies this; at La Jolla Institute for Immunology, an Assistant or Associate Member appointment on the institute's tenure-equivalent track satisfies this. A postdoctoral fellowship or a fixed-term research associate appointment does not qualify — those are time-limited by definition. When a Salk or LJI scientist converts from a postdoc to a faculty or member appointment, the institute's office of academic affairs can initiate EB-1B sponsorship. The permanent appointment letter anchors the job-offer requirement.
Private employers can sponsor EB-1B. The regulation allows a private employer to petition if it employs at least three full-time researchers and has documented accomplishments in the research field. San Diego biotech and genomics companies — Illumina, Dexcom, Neurocrine Biosciences, and the research arms of larger pharma with local campuses — routinely meet this threshold: they maintain substantial R&D departments and a documented record of patents, publications, and product development. For an industry scientist, the evidence package must document the employer's research accomplishments, and the petitioner must show recognition as outstanding in the field through publications, patents, peer review, and expert letters. Industry EB-1B is filed less often than self-petitioned EB-1A because many qualified industry scientists prefer the employer-independent path — but EB-1B is available where the company is willing to sponsor.
EB-1B requires recognition as outstanding in the specific academic field — lower than EB-1A's extraordinary ability (the small percentage at the very top of the field) but higher than NIW's well-positioned standard. The typical San Diego EB-1B profile: a strong publication record in high-impact journals with growing citations, service on NIH or NSF study sections or journal editorial boards, a research award from a scientific society, and recognition by peers in expert letters that describe the researcher's standing relative to others in the subspecialty. Because EB-1B requires at least three years of experience in the field — doctoral research usually counts — it is generally accessible to scientists who are one to several years past the PhD, once a faculty or member appointment is in place.
The mechanics are similar, but UC San Diego's process is more standardized because it is a large public university with an established International Faculty and Scholars Office. For a UCSD ladder-rank faculty appointment (Assistant Professor and above) in the School of Medicine, Jacobs School of Engineering, or Scripps Institution of Oceanography, the department initiates the EB-1B request and the campus immigration office coordinates the I-140 filing with counsel. The independent institutes — Salk, Scripps Research, LJI, Sanford Burnham Prebys — operate smaller immigration teams, so the timeline and the degree of institutional initiative vary more by institute and department. In all cases, the scientist (through counsel) prepares the evidence package: publications, citation analysis, expert letters, peer review records, and awards.
Where the employer is willing to sponsor and the record supports it, filing both is the strongest strategy. EB-1B (employer-sponsored) and EB-1A (self-petitioned) are both EB-1 preference categories and both avoid PERM. Filing both produces two independent I-140s: if one is denied or the petitioner changes jobs, the other survives. For San Diego scientists at Salk, Scripps Research, or LJI, the common pattern is to have the institute sponsor EB-1B while the scientist simultaneously self-petitions EB-1A — the EB-1A is employer-independent, so it follows the scientist to a new institute or into industry. For Indian and Chinese nationals facing the EB-1 backlog, filing both as early as the record allows locks in the earliest possible priority date in the EB-1 category.
